Centers for Disease Control and Prevention

Description

The purpose of the project is to evaluate the clinical laboratory best practice recommendations for reducing blood sample hemolysis rates developed through the Laboratory Medicine Best PracticesTM (LMBPTM) Initiative of the Centers for Disease Control and Prevention. These recommendations were the product of a systematic review for evidence of effectiveness for practices to reduce hemolysis and were developed using the A6 Method established through the LMBPTM Initiative. The project seeks to measure the extent of improvement that results from implementation of these evidence-based best practice recommendations. The project can be implemented as a study conducted in multiple institutions or facilities in a healthcare system. The purpose is limited to quality improvement associated with delivering healthcare, and the associated measuring and reporting of performance data.

Who can apply

• State governments
• County governments
• City or township governments
• Special district governments
• Independent school districts
• Public and State controlled institutions of higher education
• Native American tribal governments (Federally recognized)
• Public housing authorities / Indian housing authorities
• Native American tribal organizations (other than Federally recognized)
• Nonprofits with 501(c)(3) status (other than higher education)
• Nonprofits without 501(c)(3) status (other than higher education)

Contact

Paramjit Sandhu<br/>hkx9@cdc.gov<br/>
hkx9@cdc.gov